LFMD
LifeMD Inc

3,597
Mkt Cap
$187.1M
Volume
12,105.00
52W High
$15.84
52W Low
$2.56
PE Ratio
-19.62
LFMD Fundamentals
Price
$3.90
Prev Close
$4.09
Open
$4.09
50D MA
$3.38
Beta
1.71
Avg. Volume
898,611.47
EPS (Annual)
-$0.2263
P/B
7.86
Rev/Employee
$498,856.55
$123.43
Loading...
Loading...
News
all
press releases
LifeMD, Inc. (NASDAQ:LFMD) Given Average Recommendation of "Moderate Buy" by Brokerages
Shares of LifeMD, Inc. (NASDAQ:LFMD - Get Free Report) have been given an average recommendation of "Moderate Buy" by the nine analysts that are covering the company, MarketBeat.com reports. One...
MarketBeat·6d ago
News Placeholder
More News
News Placeholder
LifeMD CFO Marc Benathen Steps Down, Atul Kavthekar Named Replacement
(RTTNews) - LifeMD, Inc. (LFMD), a direct-to-patient telehealth company, Monday announced that its chief financial officer, Marc Benathen has resigned to pursue a new opportunity. Atul Kavthekar has...
Nasdaq News: Markets·7d ago
News Placeholder
LifeMD Appoints Atul Kavthekar CFO As Marc Benathen Departs; Names Pisano CMO, Friedeman CBO
(RTTNews) - LifeMD Inc. (LFMD, LFMDP) on Monday appointed Atul Kavthekar as chief financial officer, effective immediately, as current CFO Marc Benathen will depart to pursue another opportunity and...
Nasdaq News: Markets·7d ago
News Placeholder
LifeMD (NASDAQ:LFMD) Raised to Outperform at Mizuho
Mizuho raised shares of LifeMD from a "neutral" rating to an "outperform" rating and increased their target price for the company from $6.00 to $8.00 in a report on Monday...
MarketBeat·7d ago
News Placeholder
LifeMD (NASDAQ:LFMD) Upgraded to Hold at Wall Street Zen
Wall Street Zen raised LifeMD from a "sell" rating to a "hold" rating in a report on Saturday...
MarketBeat·9d ago
News Placeholder
HC Wainwright Issues Positive Forecast for LifeMD Earnings
LifeMD, Inc. (NASDAQ:LFMD - Free Report) - Stock analysts at HC Wainwright increased their Q1 2026 earnings per share (EPS) estimates for shares of LifeMD in a research report issued to clients and...
MarketBeat·10d ago
News Placeholder
Hims & Hers Plunges 29.4% in Three Months: How to Play the Stock?
HIMS is navigating margin and regulatory pressure, but new benefits, a Novo Nordisk tie-up and platform growth could drive its next move.
Zacks·11d ago
News Placeholder
HC Wainwright Increases LifeMD (NASDAQ:LFMD) Price Target to $10.00
HC Wainwright upped their price objective on LifeMD from $9.00 to $10.00 and gave the company a "buy" rating in a research note on Wednesday...
MarketBeat·12d ago
News Placeholder
BTIG Research Reiterates Buy Rating for LifeMD (NASDAQ:LFMD)
BTIG Research restated a "buy" rating and set a $10.00 price objective on shares of LifeMD in a research report on Tuesday...
MarketBeat·13d ago
News Placeholder
LifeMD Q4 Earnings Call Highlights
LifeMD (NASDAQ:LFMD) executives highlighted strong fourth-quarter and full-year 2025 performance and outlined investment priorities for 2026, pointing to accelerating demand in its weight management...
MarketBeat·14d ago
<
1
2
...
>

Latest LFMD News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.